ANN ARBOR – Three of the nation’s largest cannabis operators — Cresco Labs, Green Thumb Industries, and Verano Holdings — have been named in a sweeping federal class-action lawsuit that alleges violations of the federal Racketeer Influenced and Corrupt Organizations Act (RICO), consumer fraud, negligent misrepresentation, and other claims tied to the marketing and sale of cannabis products.
The 320-page complaint was filed May 4 in the U.S. District Court for the Northern District of Illinois in a case titled Murray et al. v. Cresco Labs Inc. et al. The lawsuit includes more than 40 plaintiffs from 12 states, including Michigan, and seeks class-action status.
Importantly, the allegations remain unproven, and no court has ruled on the merits of the claims.
What The Lawsuit Alleges
According to court filings and reporting on the complaint, the plaintiffs allege the companies marketed cannabis products to recreational consumers using claims suggesting medical or therapeutic benefits while allegedly failing to adequately warn consumers about potential mental health and health-related risks associated with high-potency THC products.
The lawsuit compares the cannabis industry’s alleged conduct to tactics historically associated with the tobacco industry, arguing the companies promoted cannabis products as beneficial while allegedly minimizing or concealing potential harms.
The complaint further alleges that product labeling, public statements, marketing materials, and wellness-oriented branding created misleading impressions regarding safety and medical efficacy.
Plaintiffs are seeking unspecified damages and injunctive relief that could restrict future marketing claims involving recreational cannabis products.
Defendants Push Back
The companies strongly dispute the allegations.
According to MJBizDaily, a spokesperson for Verano Holdings described the lawsuit as “part of a broader litigation campaign” against multistate cannabis operators.
Industry observers also note that cannabis companies have previously defeated or secured dismissals in other cannabis-related consumer lawsuits involving potency labeling and marketing claims.
At this stage, the case represents allegations made by plaintiffs rather than factual findings by the court.
Why Michigan, Ohio And Illinois Operators Should Pay Attention
Legal analysts say the case could signal a new phase of cannabis-industry litigation that expands beyond traditional licensing and regulatory enforcement into broader product-liability and consumer-protection battles.
That could have implications not only in Illinois — where the lawsuit was filed and where all three companies are headquartered — but also in fast-growing cannabis markets such as Michigan and Ohio.
Illinois matters because many of the nation’s largest multistate operators built their early business infrastructure there, making the state a central hub for cannabis branding, compliance, and investor activity.
Michigan, meanwhile, has become one of the nation’s largest and most competitive cannabis markets, where aggressive price competition and heavy retail marketing dominate the industry landscape.
Ohio may face similar pressures as its newer adult-use cannabis market rapidly expands following legalization. Operators there are now racing to build brands, attract recreational customers, and scale operations in ways that increasingly resemble mature consumer packaged-goods industries.
Many cannabis companies already operate across multiple states through shared ownership structures, common branding strategies, licensing agreements, suppliers, and investor groups. Legal experts say that if plaintiffs successfully establish viable legal theories around labeling, potency claims, health representations, or consumer disclosures, similar lawsuits could eventually emerge in additional state markets.
Compliance And Documentation Could Become Bigger Priorities
The litigation also highlights growing concerns surrounding:
- Product labels and warning language
- Health and wellness marketing claims
- Scientific or medical references used in advertising
- Certificates of analysis (COAs) and product testing documentation
- Consumer complaint tracking
- Corrective-action procedures
- Insurance coverage and litigation preparedness
For cannabis operators in Michigan, Ohio, Illinois, and other emerging markets, the case may represent a broader warning that the industry is evolving into a more heavily litigated consumer-products sector — one increasingly resembling the legal and compliance environment faced by tobacco, alcohol, vaping, and pharmaceutical companies.
Industry attorneys and risk-management specialists say the result could be increased pressure on cannabis companies to strengthen documentation, disclosures, and compliance systems before future litigation expands deeper into the industry.
